Get 40% Off
👀 👁 🧿 All eyes on Biogen, up +4,56% after posting earnings. Our AI picked it in March 2024.
Which stocks will surge next?
Unlock AI-picked Stocks

China extends Marriott-Starwood deal review by up to 60 days

Published 08/09/2016, 01:52 AM
Updated 08/09/2016, 01:52 AM
© Reuters. Signage for the New York Marriott Marquis is seen in Manhattan, New York

By Mike Stone and Michelle Price

(Reuters) - China has extended its review of Marriott International Inc's (O:MAR) acquisition of Starwood Hotels & Resorts Worldwide Inc (N:HOT) by up to 60 days, the companies said on Monday.

China's Ministry of Commerce (MOFCOM) review is the only remaining merger clearance for the deal, which is expected to create the largest hotel group in the world with a combined enterprise value of $36 billion and 1.1 million hotel rooms.

Hilton Worldwide Holdings (N:HLT), which would be No.2 behind the combined group, has 775,000 rooms.

Marriott and Starwood did not say why MOFCOM needed more time and said their planned merger did not create any anti-competitive issues in China.

The merged group would become the largest hotel operator in China with a 4.1 percent market share, followed by Homeinns Hotel & Management at 4 percent and China Lodging Group at 3.9 percent, data from research firm Euromonitor International shows.

Marriott's deal to buy Starwood, the operator of Sheraton and Westin hotels, has been cleared by antitrust authorities in more than 40 countries and territories including the United States, the European Union and Canada.

The shareholders of both companies approved the deal in April.

MOFCOM has developed a reputation as a tough deals regulator, but it has only blocked two transactions since China's antimonopoly law came into force in 2008, compared with 1,447 unconditional clearances, according to data compiled by law firm Norton Rose Fulbright.

The regulator generally prefers to impose remedies such as asset divestments on transactions it believes could harm competition, taking this approach in 26 cases, the Norton Rose Fulbright research shows.

3rd party Ad. Not an offer or recommendation by Investing.com. See disclosure here or remove ads .

Last month, MOFCOM approved AB InBev's (BR:ABI) $100 billion-plus takeover of rival brewer SABMiller (L:SAB) subject to SABMiller divesting some Chinese assets. MOFCOM also extended InBev's review to phase-three, but did not make full use of the extra time.

A Chinese company, Anbang Insurance Group Co [ANBANG.UL], abandoned its pursuit of Starwood in April after a bidding war that resulted in Marriott increasing its cash-and-stock bid by $1 billion. The deal is currently valued at about $13.4 billion.

While Anbang had offered $14 billion in cash, an acquisition by the Chinese firm probably would have faced scrutiny by the Committee on Foreign Investment in the United States on national security grounds.

Once notorious for its lengthy review process, MOFCOM has significantly sped-up approvals over the past 18 months following the introduction of a simple case procedure that takes about 29 days. Still, complex transactions can spend months in limbo.

Deals filed via the normal procedure undergo a 30-day phase-one review, which can be extended by 90 days for phase two and by a further 60 days for the final third phase. Including pre-filing consultations with MOFCOM, a deal that goes to phase three could take nine months to clear.

Unlike the European Union, MOFCOM does not operate a specific threshold for moving beyond phase one, and may do so for administrative reasons or because the watchdog is short of resources, lawyers said.

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.